The partners at the centre of Blis patent dispute named

The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015. (Image: NZME)

Fri, 27 Sep 2024

Two executives from Blis Technologies’ long-time European partner, Bluestone Pharma, are named on a patent application as inventors of two fermentation processes Blis claims as its own technology.The executives are Michael Faber, Swiss-registered Bluestone Pharma’s managing partner, and Karsten Brandt, its chief scientific officer. The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015 to distribute its healthcare products in Europe. At the time, Blis said the relationship with Bluestone Pharma (BP) hel...

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime with two clicks, an email or a phone call.
Find out more.

We are serious about journalism.

Name {{ registerForm.errors.get('name') }}

Email address {{ registerForm.errors.get('email') }}

Phone Number {{ registerForm.errors.get('phone') }}

Job Title {{ registerForm.errors.get('title') }}

Password Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Repeat password {{ registerForm.errors.get('password_confirmation') }}

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Credit Card

Cardholder's name

{{ __(plans[index].name) | capitalize }} {{ plans[index].attributes.old_price | currency }} {{ plans[index].price | currency }}

All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service

{{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

On the Money

On the Money: Hawkesby, Paris, Mowbray, Peters, and more

Christian Hawkesby plays coy with the top job while AI threatens all the other jobs.

Dileepa Fonseka 5:00am

Environment

UN warns warming could top 1.5C in next 4 years

"We have just experienced the 10 warmest years on record."

AFP 5:00am

UN warns warming could top 1.5C in next 4 years

World

The Obama Coalition is finished. Why not his policies, too?

Congressional Republicans shouldn’t fear reforming programs that failed.

The Washington Post 5:00am

The Obama Coalition is finished. Why not his policies, too?

Sponsored

Tired of missing out on getting to global summits to help grow your business?

Airwallex is offering a grant for NZ businesses to join the action.

Airwallex

Sponsored

Ready for the C-Suite leap?

Part-time programme. Full-time leadership transformation.

University of Auckland Business School

More Markets

Markets Market Close

Lower bond yields lift NZ sharemarket

Lower bond yields have helped drive the NZ sharemarket sharply higher at the close.

Jamie Gray 30 May 2025

Markets

Turbulent market slashes 2 Cheap Cars' profit

New Zealand’s continued economic downturn, a sharp fall in immigration and consequent softer market demand has driven a 47% drop in profit for 2 Cheap Cars.The company reported total revenue of $81.9 million with 7675 cars sold in the year to March 31, down 6% compared to $86.7m...

Staff reporters 30 May 2025